Workshop on the genetic and molecular basis of the neuronal ceroid lipofuscinoses London, UK, 13-16 November 1997

European Journal of Paediatric Neurology

Volumn 2, Issue 2, 1998, Pages A3-

  Mole, Sara E ^a   Gardiner, R Mark ^a   Goebel, Hans H ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DEGENERATIVE DISEASE; GENETIC LINKAGE; GENETICS; HISTOPATHOLOGY; MULTIGENE FAMILY; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION;

EID: 0031782414     PISSN: 10903798     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1090-3798(98)80052-4     Document Type: Conference Paper

References (16)

1. Santavuori P. Neuronal ceroid lipofuscinosis in childhood. Brain Dev 1988; 10: 80-83.
2. Zeman W. Studies in the neuronal ceroid lipofuscinosis. J Neuropathol Exp Neurol 1974; 33: 1-12.
3. Mole SE. Gene table: Neuronal ceroid lipofuscinoses (NCL). Eur J Paed Neurol 1997; 5/6: 187.
4. Vesa J, Hellsten E, Verkruyse LA et al. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 1995; 376: 584-587.
5. O'Rawe A, Mitchison HM, Williams R et al. Genetic linkage analysis of a variant of juvenile onset neuronal ceroid lipofuscinosis with granular osmiophilic deposits. Neuroped 1997; 28: 21-22.
6. Soyombo AA, Hofmann SL. Molecular cloning and expression of palmitoyl-protein thioesterase 2 (PPT2), a homolog of lysosomal palmitoyl-protein thioesterase with a distinct substrate specificity. J Biol Chem 1997; 272: 27456-27463.
7. Hellsten E, Vesa J, Olkkonen VM et al. Human palmitoyl protein thioesterase: evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis. EMBO 1996; 15: 5240-5245.
8. Sleat DE, Donnelly RJ, Lackland H et al. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science 1997; 277: 1802-1805.
9. Sharp JD, Wheeler RB, Lake BD et al. Loci for classical and a variant late infantile neuronal ceroid lipfuscinoses map to chromosomes 11p15 and 15q21-23. Hum Mol Genet 1997; 6: 591-596.
10. Savukoski M, Kestila M, Williams R et al. Defined chromosomal assignment of CLN5 demonstrates that at least four genetic loci are involved in the pathogenesis of human ceroid lipofuscinoses. Am J Hum Genet 1994; 55: 695-701.
11. Munroe PB, Mitchison HM, O'Rawe AM et al. Spectrum of mutations in the Batten disease gene, CLN3. Am J Hum Genet 1997; 61: 310-316.
12. The International Batten Disease Consortium. Isolation of a novel gene underlying Batten disease (CLN3). Cell 1995; 82: 949-957.
13. Pearce DA, Sherman F. BTN1, a yeast gene corresponding to the human gene responsible for Batten's disease, is not essential for viability, mitochondrial function, or degradation of mitochondrial ATP synthase. Yeast 1997; 13: 691-697.
14. Chapman RE, Munro S. The functioning of the yeast Golgi apparatus requires an ER protein encoded by ANP1, a member of a new family of genes affecting the secretory pathway. EMBO J 1994; 13: 4896-4907.
15. Koppang N. English Setter model and juvenile ceroid-lipofuscinosis in man. Am J Med Genet 1992; 42: 599-604.
16. Bronson RT, Lake BD, Cook S et al. Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease). Ann Neurol 1993; 33: 381-385.